Skip to main content
VulnerabilityPublished

CVE-2026-133693: continuedev continue 2.0.0/2.1.0 · Path Traversal

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-133693· Medium 4.8

Not known to be exploited · CVSS 4.8 Medium.

Data as of 20 Nov 2026, 22:43 UTC

CVSS 4.0 base score
4.8Medium
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (VulDB)CVSS 4.04.8
CNA (VulDB)CVSS 3.13.3
CNA (VulDB)CVSS 3.03.3
CNA (VulDB)CVSS 2.01.7
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 20 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
continuedevcontinueAffected
  • =2.0.0
  • =2.1.0
Fixed in–

AI-suggested

Users should restrict local access to trusted personnel and monitor for any updates from the vendor regarding fixes.

Description

A path traversal weakness exists in continuedev continue versions 2.0.0 and 2.1.0 in the validateSearchAndReplaceFilepath function of the Edit Tool component. Exploitation requires local access and can lead to limited integrity impact. The vendor has not responded to disclosure requests, and no patch information is available.

References

Community reviews

Loading reviews…